.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Federal Trade Commission
Boehringer Ingelheim
QuintilesIMS
US Department of Justice
Queensland Health
US Army
Colorcon
Novartis

Generated: September 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020136

« Back to Dashboard
NDA 020136 describes DEMADEX, which is a drug marketed by Mylan Speciality Lp and Roche and is included in two NDAs. It is available from two suppliers. Additional details are available on the DEMADEX profile page.

The generic ingredient in DEMADEX is torsemide. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the torsemide profile page.

Summary for NDA: 020136

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020136

Suppliers and Packaging for NDA: 020136

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEMADEX
torsemide
TABLET;ORAL 020136 NDA Meda Pharmaceuticals 0037-3500 0037-3500-01 100 TABLET in 1 BOTTLE (0037-3500-01)
DEMADEX
torsemide
TABLET;ORAL 020136 NDA Meda Pharmaceuticals 0037-3505 0037-3505-01 100 TABLET in 1 BOTTLE (0037-3505-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Aug 23, 1993TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Aug 23, 1993TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Aug 23, 1993TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020136



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Dow
Fish and Richardson
Express Scripts
McKinsey
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
Argus Health
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot